Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Ventyx Biosciences, Inc. Common Stock (VTYX)

Pharmaceutical Preparations

https://www.ventyxbio.com

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

12790 EL CAMINO REAL, SUITE 200
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/21/2021

Market Cap

132,151,273

Shares Outstanding

59,050,000

Weighted SO

59,048,108

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ACLX --.--%

IMCR --.--%

PCVX --.--%

DICE --.--%

NUVL --.--%

CERE --.--%

TVTX --.--%

GPCR --.--%

Beta

0.3830

Last Div

0.0000

Range

1.865-38.2

Chg

-0.0500

Avg Vol

1128138

Mkt Cap

132151273

Exch

NASDAQ

Country

US

Phone

760 593 4832

DCF Diff

1.2176

DCF

0.6674

Div Yield

0.0000

P/S

122.8172

EV Multiple

-0.5617

P/FV

0.4699

Div Yield %

0.0000

P/E

-0.7702

PEG

0.0128

Payout

0.0000

Current Ratio

14.1919

Quick Ratio

14.1919

Cash Ratio

2.2606

DSO

169.6097

DIO

0.0000

Op Cycle

169.6097

DPO

1726.1458

CCC

-1556.5362

Gross Margin

-0.2937

Op Margin

-170.6106

Pretax Margin

-159.2026

Net Margin

-159.2026

Eff Tax Rate

-0.0460

ROA

-0.5540

ROE

-0.6143

ROCE

-0.6307

NI/EBT

1.0000

EBT/EBIT

0.9331

EBIT/Rev

-170.6106

Debt Ratio

0.0364

D/E

0.0401

LT Debt/Cap

0.0354

Total Debt/Cap

0.0386

Int Coverage

-50.6979

CF/Debt

-14.0685

Equity Multi

1.1011

Rec Turnover

2.1520

Pay Turnover

0.2115

Inv Turnover

0.0000

FA Turnover

0.0985

Asset Turnover

0.0035

OCF/Share

-2.2462

FCF/Share

-2.2532

Cash/Share

3.3936

OCF/Sales

-147.2881

FCF/OCF

1.0031

CF Coverage

-14.0685

ST Coverage

-163.2152

CapEx Coverage

-320.8138

Div&CapEx Cov

-320.8138

P/BV

0.4699

P/B

0.4699

P/S

122.8172

P/E

-0.7702

P/FCF

-0.8313

P/OCF

-0.8325

P/CF

-0.8325

PEG

0.0128

P/S

122.8172

EV Multiple

-0.5617

P/FV

0.4699

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation